Client Login
Technical Links
Adventrx ACCR 2007 presentation on “A novel emulsion formulation of Decetaxel”
Link to [http://www.adventrx.com/assets/pdfs/AACR_2007_Cancer_Therapeutics_Conference_Poster.pdf]
Adventrx news release 2008 and 2009 on FDA agreement on a single BE study approach
Link to [http://ir.adventrx.com/phoenix.zhtml?c=75414&p=irol-newsArticle&ID=1286162&highlight=]
The cancer market outlook for 2014; competitive landscape, market size, pipeline analysis and growth opportunities, Business Insights, January 4, 2010
Link to [http://www.marketresearch.com/product/display.asp?productid=2539894&partnerid=811788012]
Cancer market trends 2008 – 2012, key market forecasts and growth opportunities, URCH, January 2009
Link to [http://www.reportlinker.com/p0178098/Cancer-Market-Trends-2008-2012-Key-market-forecasts-and-growth-opportunities.html]
Generic cancer market – new legislation and a wave of patent expiration to transform the market, URCH, 2005-12-21
NeoPharm, Inc news release, January 2010
Link to [http://investor.neopharm.com/releasedetail.cfm?ReleaseID=364768]
Alternative drug formulations of Docetaxel: a review, E. Frederike; M. Ron and W. Jaap, ISSN vol 18 2007
Link to [http://journals.lww.com/anti-cancerdrugs/pages/articleviewer.aspx?year=2007&issue=02000&article=00001&type=abstract]
Taxotere preparation, Sanofi av. www.sanofi.com
